Analysis of bacteriological efficacy revealed its most pronounced and clinically significant differences between the groups : the cefotaxime/furamag combination led to higher pathogen eradication in all follow-up periods : after @ days of treatment ( @ % ) and following a complete therapy cycle ( @ % ) versus the cefotaxime monotherapy group ( @ and @ % , respectively ; p < @ ) .